EDITAS MEDICINE, INC. Proceeds from Issuance or Sale of Equity
EDITAS MEDICINE, INC. (EDIT) reported Proceeds from Issuance or Sale of Equity of $6.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2018-03-08
- EDITAS MEDICINE, INC. proceeds from issuance or sale of equity for the quarter ending 2015-12-31 was $4.00K.
- EDITAS MEDICINE, INC. proceeds from issuance or sale of equity for fiscal 2015 was $6.00K, a 85.37% decline from fiscal 2014.
- EDITAS MEDICINE, INC. proceeds from issuance or sale of equity for fiscal 2014 was $41.00K.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|
| 2015-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $6.00K 10-K · filed 2018-03-08 | |
| 2015-09-30 | $2.00K 10-Q · filed 2016-11-09 | ||
| 2014-12-31 | $41.00K 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |